Strides Pharma Science Limited
Who owns it
Promoter holding rose 2.07pp across 8 quarters, from 25.84% to 27.91%.
38.10% of the promoter’s holding is pledged, down from 49.17% at the start of the series.
Loading the quarter figures…
Ownership shown is promoter, public and pledge.
How it trades
Loading trading data…
Splits, bonuses and rights
- 6 Dec 2024
A demerger separated part of the company out, changing both the share base and the company’s value — figures on either side of this date aren’t directly comparable. It is why this page measures delivery and turnover only from the sessions after it — a comparison across it would mix two different share structures.
Shown from Aug 2024, as far back as we can certify the record complete; earlier actions are not listed. Scheduled dividends are listed ahead of their ex-date, and past dividend ex-dates from the same window when on record — a stock with none shown either paid none in that window or predates our records; never read the absence as Strides Pharma Science Limited having paid none.
Fundamentals and valuation — we hold neither. The FII / DII / government split of public holding — not carried yet.
This page reports what Strides Pharma Science Limited disclosed to the exchange and how its shares have traded. It states no view on the stock and is not advice. Every figure is dated to the filing it came from; absence is stated, never shown as zero.